Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Coste

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Critical Care Medicine|November 18, 2021
The authors replyAnne Coste, Cécile Aubron
Pharmaceutics|February 26, 2022
Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated DataCyril Leven, Anne Coste, Camille Mané
Intensive Care Medicine|August 10, 2021
Influenza and prophylactic antifungal therapy for aspergillosis: addressing some questions firstAnne Coste, Kahaia De Longeaux, Cécile Aubron
Critical Care (London, England)|April 17, 2026
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic reviewAnne Coste, Cécile Aubron, Séverine Ansart, et al.
Critical Care (London, England)|November 26, 2025
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic reviewAnne Coste, Cécile Aubron, Séverine Ansart, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric ApproachAnne Coste, Ronan Bellouard, Guillaume Deslandes, et al.
Journal of Fungi (Basel, Switzerland)|March 29, 2023
What Is New in Pulmonary Mucormycosis?François Danion, Anne Coste, Coralie Le Hyaric, et al.
Infection|January 3, 2021
Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infectionAnne Coste, Mélanie Poinot, Sophie Panaget, et al.
International Journal of Antimicrobial Agents|June 13, 2026
Risk factors and Outcome of Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteraemia in High-Risk Neutropenic Patients in Haematology: A Multicentre Retrospective StudyWilliam Lars, Benjamin Gaborit, Anne Coste, et al.
Infectious Diseases Now|May 16, 2024
Toward an optimization of empirical antibiotic therapy in acute graft pyelonephritis: A retrospective multicenter studyPauline Martinet, Luca Lanfranco, Anne Coste, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Critical Care Medicine|November 18, 2021
The authors replyAnne Coste, Cécile Aubron
Pharmaceutics|February 26, 2022
Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated DataCyril Leven, Anne Coste, Camille Mané
Intensive Care Medicine|August 10, 2021
Influenza and prophylactic antifungal therapy for aspergillosis: addressing some questions firstAnne Coste, Kahaia De Longeaux, Cécile Aubron
Critical Care (London, England)|April 17, 2026
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic reviewAnne Coste, Cécile Aubron, Séverine Ansart, et al.
Critical Care (London, England)|November 26, 2025
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic reviewAnne Coste, Cécile Aubron, Séverine Ansart, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric ApproachAnne Coste, Ronan Bellouard, Guillaume Deslandes, et al.
Journal of Fungi (Basel, Switzerland)|March 29, 2023
What Is New in Pulmonary Mucormycosis?François Danion, Anne Coste, Coralie Le Hyaric, et al.
Infection|January 3, 2021
Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infectionAnne Coste, Mélanie Poinot, Sophie Panaget, et al.
International Journal of Antimicrobial Agents|June 13, 2026
Risk factors and Outcome of Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteraemia in High-Risk Neutropenic Patients in Haematology: A Multicentre Retrospective StudyWilliam Lars, Benjamin Gaborit, Anne Coste, et al.
Infectious Diseases Now|May 16, 2024
Toward an optimization of empirical antibiotic therapy in acute graft pyelonephritis: A retrospective multicenter studyPauline Martinet, Luca Lanfranco, Anne Coste, et al.
Pageof 2